Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling
about
Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formationRegulatory variation at glypican-3 underlies a major growth QTL in miceAdvances in liver cancer antibody therapies: a focus on glypican-3 and mesothelinOvergrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian hedgehogThe loss of glypican-3 induces alterations in Wnt signalingDally-like core protein and its mammalian homologues mediate stimulatory and inhibitory effects on Hedgehog signal responseLoss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular developmentRaised late pregnancy glucose concentrations in mice carrying pups with targeted disruption of H19delta13PLAC1, a trophoblast-specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor.Co-evolution of X-chromosome inactivation and imprinting in mammals.Glypican-3: a new target for cancer immunotherapy.Increased placental glucose transport rates in pregnant mice carrying fetuses with targeted disruption of their placental-specific Igf2 transcripts are not associated with raised circulating glucose concentrations.Simpson-Golabi-Behmel syndrome types I and II.Heparan sulfate proteoglycans.Reductions in expression of growth regulating genes in skeletal muscle with age in wild type and myostatin null miceDisruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism.Nik-related kinase regulates trophoblast proliferation and placental development by modulating AKT phosphorylation.Programming placental nutrient transport capacity.Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.let-7 and miR-140 microRNAs coordinately regulate skeletal development.Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis.3-M syndrome: a growth disorder associated with IGF2 silencing.Gestational diabetes: risk factors and recent advances in its genetics and treatment.Boning up on glypicans--opportunities for new insights into bone biology.Biological features of placental programming.LRP1 mediates Hedgehog-induced endocytosis of the GPC3-Hedgehog complex.X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndrome.Mosaic analysis of insulin receptor function.Craniofacial skeletal defects of adult zebrafish Glypican 4 (knypek) mutants.Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements.Perlecan: an important component of the cartilage pericellular matrix.The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor.Glypican-3 is overexpressed in human hepatocellular carcinoma.Distinctive findings in a boy with Simpson-Golabi-Behmel syndrome.A patient with a unique frameshift mutation in GPC3, causing Simpson-Golabi-Behmel syndrome, presenting with craniosynostosis, penoscrotal hypospadias, and a large prostatic utricleDynamic Expression of Genes Involved in Proteoglycan/Glycosaminoglycan Metabolism during Skin DevelopmentOntology-based validation and identification of regulatory phenotypes
P2860
Q24650523-A81CC40D-4DFE-474A-AE51-BBEFE5D794B0Q24806137-C9784841-BB37-4A82-9BD9-38824859BDB3Q27015134-83A268D8-BFDB-464C-8DD4-9D19F5F28885Q28509029-BA870A6B-EA9D-4022-9DDE-EF25B83C854DQ28575434-371100E0-8E6B-464F-A975-4429CDFDFC1AQ28583887-409499F4-78CB-4AE2-B902-A2DBDC3F44C4Q28587262-B2EDB1F4-DA43-4A2B-895F-0D1ACC554E0CQ33556605-DECC99E9-8141-4240-9237-BC069CA3A83EQ34157357-DEB208DB-15ED-4927-9C5A-B032003C3E0AQ34409829-CAEAC0DC-650E-4D54-94B5-B2C28B2A9E7AQ34543102-4756011B-0B1B-456A-8974-5E66CF377335Q34572315-5895D554-D333-443B-9026-F35E6CF5957EQ34623852-8CD7E58D-5D47-4B55-8636-8807D7AA8BF9Q35059448-41224EC0-297B-4BE0-8964-A24E4FE3AEE8Q35134305-9A290E68-4565-44A1-98B9-F19AAC588C5DQ35167917-211D50AD-628C-4D24-A5F8-F70617213D2EQ36267711-B0C02577-F0FD-4E4F-80A4-12CB2818A26DQ36378618-752EF8EB-4C59-48C7-AB3A-6EE914965B32Q36475859-7D4C36D8-FE69-4C43-9BF0-AD621584DCC2Q37143645-F1B4F8CB-33DD-47D6-97EF-12B33F2C7E36Q37351931-3B22BE17-966B-4318-9429-B2645BD63912Q37358224-EE4D22A8-96CB-48C6-A54D-9D9B5D43FCDEQ37757271-36EDDBDB-8C3A-4A3E-A09E-FAF960E7F745Q38072394-03245910-9635-490F-AC36-0DA02B0F980FQ38798118-9A9B4B05-0F3D-4DA5-8898-1AC20B513C46Q39370794-999A90FD-3D18-404E-85FD-280B60ECC66FQ40156896-4A8358AD-EF77-46CD-AE8C-E138F567F2F7Q40413498-89FA7F1B-8D72-46CE-87C1-E30954AE20DBQ41520660-929D4CC1-0181-4E85-AA10-875131B68943Q41871371-D5756ABE-4AA3-4016-AE91-5A292FAE142CQ43229719-809DE945-9DC8-4172-92EE-5950372A3348Q44484399-0457D2B2-1EE0-4C33-B0B8-200D44E27A63Q53654099-4BE1FE7C-3DC3-42B3-92C8-B9353FC28751Q53779473-74D81533-44D8-4EEE-9615-565B35DA535BQ56266950-776343D7-6F54-4854-83DC-A8065DB839B2Q58693400-8E7E94A9-C13F-436E-BE4C-C74F3B15F1B4Q58757847-DD7BAD2F-A2B2-473E-A71A-C97A4B13352D
P2860
Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling
description
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im März 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/03/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/03/01)
@nl
наукова стаття, опублікована в березні 2002
@uk
مقالة علمية (نشرت في مارس 2002)
@ar
name
Overgrowth of a mouse model of ...... s independent of IGF signaling
@ast
Overgrowth of a mouse model of ...... s independent of IGF signaling
@en
Overgrowth of a mouse model of ...... s independent of IGF signaling
@nl
type
label
Overgrowth of a mouse model of ...... s independent of IGF signaling
@ast
Overgrowth of a mouse model of ...... s independent of IGF signaling
@en
Overgrowth of a mouse model of ...... s independent of IGF signaling
@nl
prefLabel
Overgrowth of a mouse model of ...... s independent of IGF signaling
@ast
Overgrowth of a mouse model of ...... s independent of IGF signaling
@en
Overgrowth of a mouse model of ...... s independent of IGF signaling
@nl
P2093
P50
P356
P1476
Overgrowth of a mouse model of ...... s independent of IGF signaling
@en
P2093
Eric Chiao
Ioannis Dragatsis
Peter Fisher
P304
P356
10.1006/DBIO.2001.0554
P407
P577
2002-03-01T00:00:00Z